Optimal concentration of Lugol's solution for detecting early esophageal carcinoma: A randomized controlled trial
Journal of Gastroenterology and Hepatology · 2023
DOI: 10.1111/jgh.16190 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Jun-Yan Qu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Shandong Province, Shandong Province and National Clinical Research Center for Digestive Diseases.
Abstract (Originalsprache)
Background and Aim Lugol chromoendoscopy is the standard technique to detect an esophageal squamous cell carcinoma (ESCC). However, a high concentration of Lugol's solution can induce mucosal injury and adverse events. We aimed to investigate the optimal concentration of Lugol's solution to reduce mucosal injury and adverse events without degrading image quality.
Methods
This was a two‐phase double‐blind randomized controlled trial. In phase I, 200 eligible patients underwent esophagogastroduodenoscopy and then were randomly (1:1:1:1:1) sprayed with 1.2%, 1.0%, 0.8%, 0.6%, or 0.4% Lugol's solution. Image quality, gastric mucosal injury, adverse events, and operation satisfaction were compared to investigate the minimal effective concentration. In phase II, 42 cases of endoscopic mucosectomy for early ESCC were included. The patients were randomly assigned (1:1) to the minimal effective (0.6%) or conventional (1.2%) concentration of Lugol's solution for further comparison of the effectiveness.
Results
In phase I, the gastric mucosal injury was significantly reduced in 0.6% group ( P < 0.05). Furthermore, there was no statistical significance in image quality between 0.6% and higher concentrations of Lugol's solution ( P > 0.05, respectively). It also showed that the operation satisfaction decreased in 1.2% group compared with the lower concentration groups ( P < 0.05). In phase II, the complete resection rate was 100% in both groups, while 0.6% Lugol's solution showed higher operation satisfaction (W = 554.500, P = 0.005).
Conclusions
The study indicates that 0.6% might be the optimal concentration of Lugol's solution for early detection and delineation of ESCC, considering minimal mucosal injury and satisfied image. The registry of clinical trials: ClinicalTrials.gov (NCT03180944).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Yue-Yue Li, Yan-Qing Li, Xiu-Li Zuo
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Shandong Province
- Shandong Province and National Clinical Research Center for Digestive Diseases
- Shandong Natural Science Foundation
- Key Technology Research and Development Program of Shandong
- Natural Science Foundation of Shandong Province
Zitieren
APA
Qu, J. Y., Li, Y., Liu, G. Q., Li, Z., Zhong, N., Zhang, M. M., Li, Y. Y., Yu, T., Lu, X. F., Li, L. X., Liu, H., Qi, Q. Q., Li, Y. Q., & Zuo, X. L. (2023). Optimal concentration of Lugol's solution for detecting early esophageal carcinoma: A randomized controlled trial. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16190
Vancouver
Qu JY, Li Y, Liu GQ, Li Z, Zhong N, Zhang MM, et al. Optimal concentration of Lugol's solution for detecting early esophageal carcinoma: A randomized controlled trial. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16190
BibTeX
@article{Qu2023,
author = {Qu, Jun-Yan and Li, Yan and Liu, Guan-Qun and Li, Zhen and Zhong, Ning and Zhang, Ming-Ming and Li, Yue-Yue and Yu, Tao and Lu, Xue-Feng and Li, Li-Xiang and Liu, Han and Qi, Qing-Qing and Li, Yan-Qing and Zuo, Xiu-Li},
title = {Optimal concentration of Lugol's solution for detecting early esophageal carcinoma: A randomized controlled trial},
journal = {Journal of Gastroenterology and Hepatology},
year = {2023},
doi = {10.1111/jgh.16190}
}
EUVIMED